temsirolimus: "serial blood samples were collected for 168-h after start of temsirolimus infusion" should be replaced with: "serial blood samples were collected in the first 168 h after start of temsirolimus infusion".
the author would like to correct the errors in the publication of the original article. the corrected details are given below for your reading.
Page 1032 Table 1 Pharmacokinetic parameters of lenalidomide alone and in the presence of digoxin, quinidine, or temsirolimus Geometric mean (geometric CV%) data are presented for all parameters except for T max where median (range) data are presented AUC area under the plasma concentration curve, AUC t auC from time zero to the last measurable concentration, AUC ∞ auC from time zero to infinity, CL R renal clearance, C max maximum observed plasma concentration; fe, cumulative urinary excretion as a percentage of administered dose, ND not determined, t 1/2 z terminal-phase half-life, T max time to reach C max Pharmacokinetic parameter Lenalidomide (10 mg) Lenalidomide (25 mg) Lenalidomide (25 mg) alone (n = 17) +Digoxin (n = 17) alone (n = 14) +Quinidine (n = 14) alone (n = 17) +temsirolimus (n = 11) 
